[1] 何权瀛. 2022年版GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解析.中国医药导刊,2022,24(2):111-115.
[2] Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health [CPH] study):a national cross-sectional study.Lancet,2018,391(10131):1706-1717.
[3] Cortegiani A,Longhini F,Madotto F,et al.High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation:a multicenter non-inferiority randomized trial.Crit Care,2020,24(1):692.
[4] 王少玲,黄金月.延续护理实践的现状与发展趋势.中国护理管理,2017,17(4):433-438.
[5] 周哲静,徐维维,俞秋波.非小细胞肺癌患者多学科合作的肺康复管理模式的构建.中国防痨杂志,2024,46(S2):239-242.
[6] 屈春瑾,彭佳怡,刘鈊逸,等.慢性阻塞性肺疾病患者延续性护理研究进展.结核与肺部疾病杂志,2024,5(3):254-259. |
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
